CyGenica has developed a biomolecular device for the programmed delivery of therapeutic molecules directly into living cells.
Please tell us a little bit about yourself and why you'd like to connect. CyGenica Ltd. + SOSV will follow up with you via email.
CEO & Co-Founder
YOU MIGHT ALSO BE INTERESTED IN
Developing an immune tolerance platform for biologics
Drugging the undruggable
Cell immunotherapy for cancers